SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-245816
Filing Date
2023-09-28
Accepted
2023-09-28 17:25:54
Documents
12
Period of Report
2023-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d534386d8ka.htm   iXBRL 8-K/A 22937
  Complete submission text file 0001193125-23-245816.txt   146378

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20230626.xsd EX-101.SCH 2860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20230626_lab.xml EX-101.LAB 17943
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20230626_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d534386d8ka_htm.xml XML 4240
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19311 | Film No.: 231291010
SIC: 2836 Biological Products, (No Diagnostic Substances)